JP2017533181A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017533181A5 JP2017533181A5 JP2017514354A JP2017514354A JP2017533181A5 JP 2017533181 A5 JP2017533181 A5 JP 2017533181A5 JP 2017514354 A JP2017514354 A JP 2017514354A JP 2017514354 A JP2017514354 A JP 2017514354A JP 2017533181 A5 JP2017533181 A5 JP 2017533181A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- acid sequence
- amino acid
- internal
- terminal fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462049875P | 2014-09-12 | 2014-09-12 | |
| US62/049,875 | 2014-09-12 | ||
| PCT/US2015/049741 WO2016040835A1 (en) | 2014-09-12 | 2015-09-11 | Internal protein tags |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017533181A JP2017533181A (ja) | 2017-11-09 |
| JP2017533181A5 true JP2017533181A5 (enExample) | 2018-10-18 |
| JP6814132B2 JP6814132B2 (ja) | 2021-01-13 |
Family
ID=55459623
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017514354A Active JP6814132B2 (ja) | 2014-09-12 | 2015-09-11 | 内部タンパク質タグ |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US9969991B2 (enExample) |
| EP (2) | EP3191601B1 (enExample) |
| JP (1) | JP6814132B2 (enExample) |
| WO (1) | WO2016040835A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230079494A (ko) | 2013-03-15 | 2023-06-07 | 프로메가 코포레이션 | 구조적 보완에 의한 바이오발광성의 활성화 |
| EP3191601B1 (en) * | 2014-09-12 | 2022-11-02 | Promega Corporation | Internal protein tags |
| US11365402B2 (en) * | 2014-09-12 | 2022-06-21 | Promega Corporation | Internal protein tags |
| US20200270586A1 (en) * | 2018-06-12 | 2020-08-27 | Promega Corporation | Multipartite luciferase |
| JP2020080784A (ja) * | 2018-11-29 | 2020-06-04 | シスメックス株式会社 | 融合ポリペプチド、融合ポリペプチドの製造方法、及び融合ポリペプチドをコードするｄｎａ |
| KR20220007058A (ko) * | 2019-04-10 | 2022-01-18 | 프로메가 코포레이션 | 생물발광을 이용하는 분석물 검출을 위한 조성물 및 방법 |
| US11360096B2 (en) | 2019-05-16 | 2022-06-14 | Duke University | Complex BRET technique for measuring biological interactions |
| EP4028540B1 (en) * | 2019-09-11 | 2025-01-29 | Laboratory Corporation of America Holdings | Methods and systems for the rapid detection of microorganisms using recombinant infectious agents to express an indicator subunit |
| CN110592031B (zh) * | 2019-09-25 | 2023-03-14 | 华南农业大学 | 一株S蛋白融合HiBiT的传染性支气管炎重组病毒及制备方法与应用 |
| EP4127148A1 (en) | 2020-03-25 | 2023-02-08 | Erasmus University Rotterdam Medical Center | Reporter system for radionuclide imaging |
| WO2023215505A1 (en) * | 2022-05-04 | 2023-11-09 | Promega Corporation | Modified dehalogenase with extended surface loop regions |
| WO2024229422A2 (en) * | 2023-05-04 | 2024-11-07 | Promega Corporation | Complementation-based tags and reporters for dual-modality labeling |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5914095A (en) | 1989-04-07 | 1999-06-22 | Salutar, Inc. | Polychelants containg amide bonds |
| US5368484A (en) | 1992-05-22 | 1994-11-29 | Atari Games Corp. | Vehicle simulator with realistic operating feedback |
| CA2146990A1 (en) | 1992-10-14 | 1994-04-28 | Robert A. Snow | Chelating polymers |
| GB9503969D0 (en) | 1995-02-28 | 1995-04-19 | Sams Bernard | Incrementing mechanism |
| US7268229B2 (en) | 2001-11-02 | 2007-09-11 | Promega Corporation | Compounds to co-localize luminophores with luminescent proteins |
| US20090149338A1 (en) * | 2005-09-30 | 2009-06-11 | Hughes Thomas E | System for detecting protein-protein interactions |
| PL3744834T3 (pl) | 2009-05-01 | 2026-01-05 | Promega Corporation | Syntetyczne lucyferazy z krewetki oplορηorus emitującej bardziej intensywne światło |
| EP2635582B1 (en) | 2010-11-02 | 2016-01-27 | Promega Corporation | Novel coelenterazine substrates and methods of use |
| CN104871001B (zh) * | 2012-12-12 | 2018-09-11 | 普洛麦格公司 | 使用细胞内生物发光共振能量转移识别生物活性剂的细胞靶标结合 |
| KR20230079494A (ko) * | 2013-03-15 | 2023-06-07 | 프로메가 코포레이션 | 구조적 보완에 의한 바이오발광성의 활성화 |
| EP3191601B1 (en) * | 2014-09-12 | 2022-11-02 | Promega Corporation | Internal protein tags |
-
2015
- 2015-09-11 EP EP15839671.3A patent/EP3191601B1/en active Active
- 2015-09-11 US US14/852,096 patent/US9969991B2/en active Active
- 2015-09-11 JP JP2017514354A patent/JP6814132B2/ja active Active
- 2015-09-11 EP EP22204685.6A patent/EP4219736A1/en active Pending
- 2015-09-11 WO PCT/US2015/049741 patent/WO2016040835A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017533181A5 (enExample) | ||
| Lipatova et al. | Direct interaction between a myosin V motor and the Rab GTPases Ypt31/32 is required for polarized secretion | |
| Rai | Peptide and protein mimetics by retro and retroinverso analogs | |
| Liu et al. | Interplay between bacterial deubiquitinase and ubiquitin E3 ligase regulates ubiquitin dynamics on Legionella phagosomes | |
| JP2016519065A5 (enExample) | ||
| DK1987178T3 (en) | Process for the construction and screening of peptide structure libraries | |
| Lürick et al. | Multivalent Rab interactions determine tether-mediated membrane fusion | |
| Yperman et al. | Molecular architecture of the endocytic TPLATE complex | |
| US9447170B2 (en) | Modified Stefin A scaffold proteins | |
| JP2024054136A5 (enExample) | ||
| Eckert et al. | Spastin's microtubule-binding properties and comparison to katanin | |
| EP3044322A1 (en) | Bimolecular protease-based biosensor | |
| Morisaki et al. | Quantifying single mRNA translation kinetics in living cells | |
| Weiser et al. | Investigation of N-terminal phospho-regulation of uracil DNA glycosylase using protein semisynthesis | |
| Kellermann et al. | Tetramolecular fluorescence complementation for detection of specific RNAs in vitro | |
| Yoo et al. | Directed evolution of highly selective proteases using a novel FACS based screen that capitalizes on the p53 regulator MDM2 | |
| US8586708B2 (en) | Monovalent streptavidin compositions | |
| Smet-Nocca et al. | The thymine− DNA glycosylase regulatory domain: Residual structure and DNA binding | |
| Cernikova et al. | Phosphoinositide-binding proteins mark, shape and functionally modulate highly-diverged endocytic compartments in the parasitic protist Giardia lamblia | |
| US20210254047A1 (en) | Proximity interaction analysis | |
| Linhartova et al. | Sequence and structural determinants of RNAPII CTD phase-separation and phosphorylation by CDK7 | |
| Eldridge et al. | An in vitro selection strategy for conferring protease resistance to ligand binding peptides | |
| Elfaki et al. | Identification and characterization of peptides that bind the PPIase domain of Parvulin17 | |
| Takeda et al. | CP5 system, for simple and highly efficient protein purification with a C-terminal designed mini tag | |
| Denholt et al. | Identification of novel peptide ligands for the cancer‐specific receptor mutation EFGRvIII using a mixture‐based synthetic combinatorial library |